Direct Detection of Viruses and Chlamydia in Clinical Samples (Englisch)
- Neue Suche nach: Leber, Amy L.
In:
Clinical Microbiology Procedures Handbook
;
10.7.1-10.7.10
;
2016
-
ISBN:
- Aufsatz/Kapitel (Buch) / Elektronische Ressource
-
Titel:Direct Detection of Viruses and Chlamydia in Clinical Samples
-
Beteiligte:Leber, Amy L. ( Herausgeber:in )
-
Erschienen in:Clinical Microbiology Procedures Handbook ; 10.7.1-10.7.10
-
Verlag:
- Neue Suche nach: ASM Press
-
Erscheinungsort:Washington, DC, USA
-
Erscheinungsdatum:15.05.2016
-
Format / Umfang:10 pages
-
ISBN:
-
DOI:
-
Medientyp:Aufsatz/Kapitel (Buch)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis E-Book
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1.1
-
Index| 2016
- 1.1.1
-
Introduction| 2016
- 1.2.1
-
Procedure Coding, Reimbursement, and Billing Compliance| 2016
- 2.1.1
-
Collection, Transport, and Manipulation of Clinical Specimens and Initial Laboratory Concerns| 2016
- 3.2.1.1
-
Staining Procedures| 2016
- 3.3.1.1
-
Processing, Isolation, Detection, and Interpretation of Aerobic Bacteriology Cultures| 2016
- 3.4.1.1
-
Blood Cultures| 2016
- 3.5.1
-
Body Fluid Cultures (Excluding Blood, Cerebrospinal Fluid, and Urine)| 2016
- 3.6.1
-
Diagnosis of Catheter‐Related Bloodstream Infection: Differential‐Time‐to‐Positivity Cultures and Catheter Tip Cultures| 2016
- 3.7.1
-
Cerebrospinal Fluid Cultures| 2016
- 3.8.1.1
-
Fecal and Other Gastrointestinal Cultures and Toxin Assays| 2016
- 3.9.1.1
-
Genital Cultures| 2016
- 3.10.1
-
Ocular Cultures| 2016
- 3.11.1.1
-
Respiratory Tract Cultures| 2016
- 3.12.1
-
Urine Cultures| 2016
- 3.13.1.1
-
Wound Cultures| 2016
- 3.14.1
-
Leptospira Culture| 2016
- 3.15.1.1
-
Detection of Human Mycoplasmas and Ureaplasmas from Clinical Specimens by Culture and PCR| 2016
- 3.16.1
-
Guidelines for Biochemical Identification of Aerobic Bacteria| 2016
- 3.17.1.1
-
Biochemical Tests for the Identification of Aerobic Bacteria| 2016
- 3.18.1.1
-
Identification of Gram‐Positive Bacteria| 2016
- 4.2.1
-
Collection, Transport, and Processing of Clinical Specimens for Anaerobic Culture| 2016
- 4.3.1
-
Culture Media for Anaerobes| 2016
- 4.4.1
-
Incubation Techniques for Anaerobic Bacteriology Specimens| 2016
- 4.5.1
-
Examination of Primary Culture Plates for Anaerobic Bacteria| 2016
- 4.6.1.1
-
Rapid Disk, Spot Tests, and Other Rapid or Primary Methods for the Identification of Anaerobes| 2016
- 4.7.1
-
Commercial Kit Overnight Biochemical Systems for the Identification of Anaerobes| 2016
- 4.8.1
-
Rapid Enzymatic Systems for the Identification of Anaerobes| 2016
- 4.9.1.1
-
Rapid Biochemical Tests (4 Hours or Less) for the Identification of Anaerobes| 2016
- 4.10.1
-
Use of Matrix‐Assisted Laser Desorption Ionization–Time of Flight for the Identification of Anaerobic Bacteria| 2016
- 4.11.1
-
Anaerobic Gram‐Negative Bacilli| 2016
- 4.12.1
-
Anaerobic Gram‐Positive Bacilli| 2016
- 4.13.1
-
Anaerobic Cocci| 2016
- 4.14.1
-
Suggestions for a Practical Scheme for the Workup of Anaerobic Cultures| 2016
- 4.15.1
-
Clostridium difficile as a Pathogen Involved in Antimicrobial Agent‐Associated Diarrhea, Colitis, and Pseudomembranous Colitis| 2016
- 5.1.1
-
Disk Diffusion Test| 2016
- 5.2.1.1
-
Broth Microdilution Test| 2016
- 5.3.1
-
Etest| 2016
- 5.4.1.1
-
Agar Dilution MIC Test| 2016
- 5.5.1
-
Beta‐Lactamase Tests| 2016
- 5.6.1
-
Oxacillin Salt‐Agar Screen Test To Detect Oxacillin (Methicillin)‐Resistant Staphylococcus aureus| 2016
- 5.7.1
-
Detection of VRSA, VISA, and Vancomycin‐Heteroresistant Staphylococcus aureus (hVISA)| 2016
- 5.8.1
-
Screening Tests for Detection of High‐Level Mupirocin Resistance in Staphylococcus aureus| 2016
- 5.9.1
-
Detection of Inducible Clindamycin Resistance in Staphylococcus spp., Streptococcus pneumoniae, and Streptococcus spp. Beta‐Hemolytic Group| 2016
- 5.10.1
-
Screen Tests To Detect High‐Level Aminoglycoside Resistance in Enterococcus spp.| 2016
- 5.11.1
-
Agar Screen Test To Detect Vancomycin Resistance in Enterococcus spp.| 2016
- 5.12.1
-
Extended‐Spectrum Beta‐Lactamase Testing for Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis| 2016
- 5.13.1
-
The Modified Hodge Confirmatory Test (or the Carbapenem Inactivation Test) for Carbapenemase Production in Enterobacteriaceae| 2016
- 5.14.1.1
-
Minimum Bactericidal Concentration Testing| 2016
- 5.15.1
-
Serum Inhibitory and Bactericidal Titers| 2016
- 5.16.1
-
Synergism Testing: Broth Microdilution Checkerboard and Broth Macrodilution Methods| 2016
- 5.17.1
-
Quality Assurance Measures for Antimicrobial Susceptibility Testing| 2016
- 5.18.1
-
Evaluation and Verification of Antimicrobial Susceptibility Test Systems| 2016
- 5.19.1
-
Selecting Antimicrobial Agents for Testing and Reporting| 2016
- 5.20.1.1
-
Preparation of Routine Media and Reagents Used in Antimicrobial Susceptibility Testing| 2016
- 5.21.1
-
Preparation of Broth Microdilution MIC Trays| 2016
- 5.22.1.1
-
Appendixes| 2016
- 6.2.1
-
Specimen Examination and Primary Isolation| 2016
- 6.3.1
-
Media and Methods Used for Phenotypic Characterization of Aerobic Actinomycetes| 2016
- 6.4.1
-
Molecular Identification| 2016
- 6.5.1
-
Susceptibility Testing| 2016
- 7.2.1.1
-
General Mycobacterial Procedures| 2016
- 7.3.1
-
Solid Media Used for Isolation| 2016
- 7.4.1.1
-
Liquid Media Used for Isolation| 2016
- 7.5.1.1
-
Identification of Mycobacteria| 2016
- 7.6.1.1
-
Nucleic Acid Amplification Procedures for Identification from Specimen| 2016
- 7.7.1.1
-
Susceptibility Testing by Liquid Media Methods| 2016
- 7.8.1
-
Susceptibility Testing by Agar Proportion Method for Mycobacterium tuberculosis Complex| 2016
- 7.9.1.1
-
Susceptibility Testing by TREK Sensititre Microdilution Plates| 2016
- 8.1.1
-
Introduction and General Considerations| 2016
- 8.2.1
-
Specimen Selection, Collection, and Transport| 2016
- 8.3.1.1
-
Specimen Examination| 2016
- 8.4.1
-
Processing Specimens for Fungal Culture| 2016
- 8.5.1
-
Examination and Evaluation of Primary Cultures| 2016
- 8.6.1
-
Presumptive Identification Tests for Yeasts Isolated on Primary Culture| 2016
- 8.7.1
-
Identification of Moulds on Primary Culture| 2016
- 8.8.1
-
Full Identification of Yeasts| 2016
- 8.9.1
-
Mould Identification| 2016
- 8.10.1.1
-
Antifungal Susceptibility Testing| 2016
- 9.2.1
-
Collection and Preservation of Fecal Specimens| 2016
- 9.3.1.1
-
Macroscopic and Microscopic Examination of Fecal Specimens| 2016
- 9.4.1.1
-
Special Stains for Coccidia and Microsporidia| 2016
- 9.5.1.1
-
Additional Techniques for Stool Examination| 2016
- 9.6.1.1
-
Other Specimens from the Intestinal Tract and the Urogenital System| 2016
- 9.7.1.1
-
Sputum, Aspirates, and Biopsy Material| 2016
- 9.8.1.1
-
Detection of Blood Parasites| 2016
- 9.9.1.1
-
Culture| 2016
- 9.10.1.1
-
Appendix 9.10.1–1—Identification Aids: Artifacts| 2016
- 10.1.1
-
Laboratory Diagnosis of Viral Infections: Introduction| 2016
- 10.2.1
-
Selection, Maintenance, and Observation of Uninoculated Monolayer Cell Cultures| 2016
- 10.3.1
-
Cell Culture Techniques: Serial Propagation and Maintenance of Monolayer Cell Cultures| 2016
- 10.4.1
-
Specimen Collection and Processing| 2016
- 10.5.1
-
Viral Culture: Isolation of Viruses in Cell Cultures| 2016
- 10.6.1
-
Isolation of Chlamydia spp. in Cell Culture| 2016
- 10.7.1
-
Direct Detection of Viruses and Chlamydia in Clinical Samples| 2016
- 11.1.1.1
-
Immunology Introduction| 2016
- 11.2.1.1
-
Serologic Diagnosis of Group A Streptococcal Infections| 2016
- 11.3.1
-
Detection of Legionella Antigen by Direct Immunofluorescence| 2016
- 11.4.1.1
-
Laboratory Diagnosis of Syphilis| 2016
- 11.5.1
-
Detection of Borrelia burgdorferi Antibodies| 2016
- 11.6.1.1
-
Serodiagnosis of Rickettsial Infections| 2016
- 11.7.1
-
Virology Introduction| 2016
- 11.8.1.1
-
Human Immunodeficiency Virus Serology| 2016
- 11.9.1.1
-
Epstein‐Barr Virus| 2016
- 11.10.1.1
-
Cytomegalovirus Serology| 2016
- 11.11.1.1
-
Herpes Simplex Virus 1 and 2 Serology| 2016
- 11.12.1.1
-
Flow Cytometry| 2016
- 11.13.1.1
-
Whole‐Blood Lymphocyte Immunophenotyping Using Cell Surface Markers by Flow Cytometry| 2016
- 11.14.1.1
-
Natural Killer Cell Assays| 2016
- 11.15.1.1
-
Dendritic Cell Assays| 2016
- 11.16.1.1
-
Neutrophil Assays| 2016
- 11.17.1.1
-
Peripheral Blood Mononuclear Cells| 2016
- 11.18.1
-
Lymphocyte Proliferation Assay| 2016
- 11.19.1.1
-
Measurement of Antigen‐Specific Cellular Responses Using the Polychromatic Flow Cytometry Intracellular Cytokine Staining Assay| 2016
- 11.20.1
-
Interferon Gamma Enzyme‐Linked Immunosorbent Spot Assay| 2016
- 11.21.1.1
-
Bead‐ and Plate‐Based Cytokine Enzyme‐Linked Immunosorbent Assays| 2016
- 12.2.1.1
-
General Aspects of Molecular Diagnostics| 2016
- 12.3.1.1
-
Molecular Methods for Identification of Cultured Microorganisms| 2016
- 12.4.1.1
-
Sequence‐Based Identification and Typing| 2016
- 12.5.1
-
Matrix‐Assisted Laser Desorption Ionization Time of Flight (MALDITOF) for Microorganism Identification| 2016
- 12.6.1
-
Appendix 12.6–1—FDA‐Cleared or Approved Nucleic Acid‐Based Tests| 2016
- 12.7.1
-
Appendix 12.7–1—Location in CMPH4 of Molecular Procedures Outside of Section 12| 2016
- 13.2.1
-
Laboratory Support for Infection Prevention: Collaboration with Benefits for All| 2016
- 13.3.1.1
-
Environmental Sampling and Cultures| 2016
- 13.4.1.1
-
Outbreak Investigations: Laboratory and Epidemiologic Concepts| 2016
- 13.5.1
-
Microbial Strain Typing for Epidemiology and Infection Control| 2016
- 13.6.1.1
-
Surveillance Cultures| 2016
- 13.7.1.1
-
Infection Control in the Laboratory| 2016
- 14.1.1
-
Quality Assessment and Improvement (Quality Assurance)| 2016
- 14.2.1
-
Quality Control| 2016
- 14.3.1
-
Laboratory Records| 2016
- 14.4.1
-
Preparation and Quality Control of Laboratory Water| 2016
- 14.5.1
-
Overview of Individualized Quality Control Plan (IQCP)| 2016
- 15.2.1.1
-
Biological Safety and Biohazard Prevention| 2016
- 15.3.1.1
-
Biohazard Containment| 2016
- 15.4.1.1
-
Laboratory Instrumentation and Equipment| 2016
- 15.5.1.1
-
Special Pathogens and Employee Safety| 2016
- 15.6.1
-
Packing and Shipping Infectious Substances| 2016
- 15.7.1
-
Management of Laboratory Accidents| 2016
- 15.8.1
-
Management of Infectious Waste| 2016
- 15.9.1
-
Risk Assessment| 2016
- 16.1.1
-
General Introduction to Bioterrorism and Emerging Infectious Diseases| 2016
- 16.2.1
-
Levels of Laboratory Safety| 2016
- 16.3.1
-
Packing and Shipping Select Agents| 2016
- 16.4.1
-
Anthrax—Bacillus anthracis| 2016
- 16.5.1
-
Botulinum Toxin—Clostridium Botulinum| 2016
- 16.6.1
-
Brucellosis—Brucella spp.| 2016
- 16.7.1
-
Plague—Yersinia pestis| 2016
- 16.8.1
-
Tularemia—Francisella tularensis| 2016
- 16.9.1
-
Melioidosis (Burkholderia pseudomallei) and Glanders (Burkholderia mallei)| 2016
- 16.10.1
-
Smallpox—Variola Major| 2016
- 16.11.1
-
Novel Influenza Viruses| 2016
- 16.12.1
-
Q Fever–Coxiella burnetii| 2016
- 16.13.1
-
Staphylococcal Enterotoxin B—Staphylococcus aureus| 2016
- 16.14.1
-
Clinical Laboratory Bioterrorism Readiness Plan| 2016
- 16.15.1.1
-
Biochemical Procedures| 2016
- i
-
Front Matter| 2016